146 related articles for article (PubMed ID: 34591695)
1. Health Care Costs and Treatment Patterns Associated with Uterine Fibroids and Heavy Menstrual Bleeding: A Claims Analysis.
Wang A; Wang S; Owens CD; Vora JB; Diamond MP
J Womens Health (Larchmt); 2022 Jun; 31(6):856-863. PubMed ID: 34591695
[No Abstract] [Full Text] [Related]
2. Treatment Patterns in Patients with Uterine Fibroids With and Without a Diagnosis of Heavy Menstrual Bleeding: Results from a Large U.S. Claims Database.
McKain L; Edsall K; Dufour R; Lickert C
J Womens Health (Larchmt); 2023 Mar; 32(3):332-340. PubMed ID: 36413048
[No Abstract] [Full Text] [Related]
3. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
Harrington A; Bonine NG; Banks E; Shih V; Stafkey-Mailey D; Fuldeore RM; Yue B; Ye JM; Ta JT; Gillard P
J Manag Care Spec Pharm; 2020 Jan; 26(1-a Suppl):S2-S10. PubMed ID: 31958025
[TBL] [Abstract][Full Text] [Related]
4. Describing the Patient Journey of Women with Claims for Uterine Fibroids and Heavy Menstrual Bleeding Using a Commercial Database (2011-2020).
Agarwal SK; Stokes M; Kung T; Tilney R; Lickert C
Int J Womens Health; 2023; 15():1561-1575. PubMed ID: 37867928
[TBL] [Abstract][Full Text] [Related]
5. Cost burden and treatment patterns associated with management of heavy menstrual bleeding.
Jensen JT; Lefebvre P; Laliberté F; Sarda SP; Law A; Pocoski J; Duh MS
J Womens Health (Larchmt); 2012 May; 21(5):539-47. PubMed ID: 22360696
[TBL] [Abstract][Full Text] [Related]
6. Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids.
Shih V; Banks E; Bonine NG; Harrington A; Stafkey-Mailey D; Yue B; Ye JM; Fuldeore RM; Gillard P
Curr Med Res Opin; 2019 Nov; 35(11):1925-1935. PubMed ID: 31290716
[No Abstract] [Full Text] [Related]
7. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
8. Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis.
Fuldeore M; Yang H; Soliman AM; Winkel C
Curr Med Res Opin; 2015; 31(9):1719-31. PubMed ID: 26153675
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and healthcare resource utilization and costs in heavy menstrual bleeding: a Japanese claims database analysis.
Akiyama S; Tanaka E; Cristeau O; Onishi Y; Osuga Y
J Med Econ; 2018 Sep; 21(9):853-860. PubMed ID: 29770717
[TBL] [Abstract][Full Text] [Related]
10. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States.
Bonine NG; Banks E; Harrington A; Vlahiotis A; Moore-Schiltz L; Gillard P
BMC Womens Health; 2020 Aug; 20(1):174. PubMed ID: 32791970
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of variation in heavy menstrual bleeding treatments by age and underlying cause.
Copher R; Le Nestour E; Law A; Pocoski J; Zampaglione E
Curr Med Res Opin; 2013 Feb; 29(2):127-39. PubMed ID: 23268728
[TBL] [Abstract][Full Text] [Related]
12. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA.
Yao X; Stewart EA; Laughlin-Tommaso SK; Heien HC; Borah BJ
BJOG; 2017 Jan; 124(2):322-330. PubMed ID: 27770484
[TBL] [Abstract][Full Text] [Related]
13. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
Schlaff WD; Ackerman RT; Al-Hendy A; Archer DF; Barnhart KT; Bradley LD; Carr BR; Feinberg EC; Hurtado SM; Kim J; Liu R; Mabey RG; Owens CD; Poindexter A; Puscheck EE; Rodriguez-Ginorio H; Simon JA; Soliman AM; Stewart EA; Watts NB; Muneyyirci-Delale O
N Engl J Med; 2020 Jan; 382(4):328-340. PubMed ID: 31971678
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids.
Stewart EA; Archer DF; Owens CD; Barnhart KT; Bradley LD; Feinberg EC; Gillispie-Bell V; Imudia AN; Liu R; Kim JH; Al-Hendy A
J Womens Health (Larchmt); 2022 May; 31(5):698-705. PubMed ID: 34582715
[No Abstract] [Full Text] [Related]
15. Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids.
Lynch SE; Mayer DC
Ann Pharmacother; 2022 Jan; 56(1):93-101. PubMed ID: 33998300
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2.
Gemzell-Danielsson K; Heikinheimo O; Zatik J; Poka R; Rechberger T; Hudecek R; Petersdorf K; Ramirez F; Faustmann T; Groettrup-Wolfers E; Seitz C
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():7-14. PubMed ID: 32559602
[TBL] [Abstract][Full Text] [Related]
17. Uterine Fibroids, Perceived Stress, and Menstrual Distress: a Key Role of Heavy Menstrual Bleeding.
Vannuccini S; Clemenza S; Cassioli E; Rossi E; Castellini G; Ricca V; Petraglia F
Reprod Sci; 2023 May; 30(5):1608-1615. PubMed ID: 36471219
[TBL] [Abstract][Full Text] [Related]
18. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
19. What are the total costs of surgical treatment for uterine fibroids?
Carls GS; Lee DW; Ozminkowski RJ; Wang S; Gibson TB; Stewart E
J Womens Health (Larchmt); 2008 Sep; 17(7):1119-32. PubMed ID: 18687032
[TBL] [Abstract][Full Text] [Related]
20. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
